Buffalo UltraSound JOINS HEALTHeLINK

BUFFALO, NY – HEALTHeLINK today announced Buffalo Ultrasound has joined Western New York’s clinical information exchange as its first mobile imaging data source. Diagnostic quality images for both radiology and echocardiography studies as well as reports from Buffalo Ultrasound’s testing centers including all mobile locations can now be securely and electronically accessed through HEALTHeLINK by more than 3,400 participating physicians.

“Having immediate access to current clinical information on a patient, including recent diagnostic imaging exams, provides value to health care professionals in being able to offer efficient and effective treatment at the point of care,” said Dan Porreca, executive director, HEALTHeLINK. “In the case of radiology exams, this information can also enhance patient safety by helping to reduce the number of unnecessary duplicate tests and in turn the amount of radiation exposure received.”

Nearly 90% of the radiology reports generated in Western New York hospitals and independent radiology centers are available to participating physicians through HEALTHeLINK.

“Buffalo Ultrasound is committed to any collaborative effort benefiting our community, especially those benefiting the frailest members confined to long term care facilities or their own home,” said Michael C. Straeck, president and CEO, Buffalo Ultrasound. “This partnership benefits everyone by expediting care and reducing costs.”

Since 1987, Buffalo Ultrasound has provided Western New York with superior quality, cost effective on site diagnostic imaging services. Family owned and operated, Buffalo Ultrasound provides imaging services and at three conveniently located testing centers in Williamsville, Kenmore and West Seneca and on site at physicians’ offices, medical centers, long term care and correctional facilities as well as for patients confined to their own home.

In addition, Buffalo Ultrasound is a trusted location for collecting patient consents. More than 700,000 Western New Yorkers have already given their health care providers better access to the information they need through HEALTHeLINK by signing a consent form. For more information or to obtain a consent form, visit wnyhealthelink.com

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.